Spruce Biosciences Inc. (SPRB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.37
-0.00 (-0.38%)
At close: Jan 15, 2025, 3:59 PM
0.36
-1.49%
After-hours Jan 15, 2025, 04:27 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -2.35 | -0.57 | -2.44 | -18.83 | -28.59 | -8.44 |
PS Ratio | 11.18 | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.47 | 0.38 | 0.94 | 3.78 | -12.35 | -4.67 |
P/FCF Ratio | -3.39 | -0.62 | -2.9 | -20.49 | -29.99 | -9.71 |
P/OCF Ratio | -3.39 | -0.62 | -2.9 | -20.55 | -30 | -9.71 |
OCF/S Ratio | -3.3 | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.06 | 0.09 | 0.06 | 0.04 | -0.15 | n/a |
Quick Ratio | 4.18 | 6.72 | 10.36 | 16.43 | 1.08 | 1.76 |
Current Ratio | 4.18 | 6.72 | 10.36 | 16.43 | 1.08 | 1.76 |
Asset Turnover | 0.10 | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -107.65 | -112.58 | -121.93 | -91.07 | -201.65 | n/a |
Return on Equity (ROE) | -0.63 | -0.66 | -0.38 | -0.2 | 0.43 | 0.55 |
Return on Assets (ROA) | -0.46 | -0.53 | -0.34 | -0.18 | -2.82 | -2.06 |
Return on Capital (ROIC) | -0.65 | -0.65 | -0.36 | -0.19 | -33.69 | -4.82 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -389.96% | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -474.96% | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -474.96% | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -515.34% | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -329.88% | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -469.48% | n/a | n/a | n/a | n/a | n/a |